| 6.58 |  +1.08 / +19.64% |
Data as of May 17 | Day’s Change |
| 6.74 | +0.16 / +2.43% |
Volume: 1.0K |
| Previous close | 5.50 |
| Today’s open | 6.18 |
| Day’s range | -- - -- |
| Volume | 3,379,397 |
| Average volume (3 months) | 311,321 |
| Market cap | $186.5M |
| Dividend yield | -- |
| Earnings growth (last year) | -180.00% |
| Earnings growth (this year) | -1.02% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +4.66% |
| P/E ratio | NM |
| Price/Sales | 3.19 |
| Price/Book | 18.76 |
| Today’s change | Today’s % change | |
|---|---|---|
| AMPEAmpio Pharmaceutical... | +0.03 | +0.60% |
| SUPNSupernus Pharmaceuti... | +0.16 | +2.74% |
| ACSTAcasti Pharma Inc | 0.00 | 0.00% |
| DRTXDurata Therapeutics ... | -0.01 | -0.14% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $32.7M |
| Annual profit (last year) | -$27.7M |
| Net profit margin | -84.53% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Mihael Hristos Polymeropoulos, MD |
CFO, Secretary, Treasurer & Senior Vice President James Patrick Kelly, CFA, MBA |
Corporate headquarters Washington, District Of Columbia |
.
